Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by beenthereon Jul 17, 2021 2:05pm
365 Views
Post# 33565368

Arrangement Between ICO & Satellos

Arrangement Between ICO & SatellosAs per previous posts I was totally against this merger but after seeing the material related to it I had a somewhat change of heart.

Sure I would like to see us have a bigger share of the pie than 27.7% but there are many factors involved to come up with a number that there is no way to try to arrive at a different number.

There is no way the average joe could figure out what is involved but I would point out page 131 which was very helpful and hellped win me over.

One of the issues I had was how the subscription receipts raised in March fit in with everything.
Well like I posted before my guess they would be subject to the 1 for 20 like everyone else and was correct.

And those shares become part of the new company's capital amounting to 13%. And the money raised by those receipts will mean we are cashed up to proceed with our business plan.

Nothing has changed with what ICO was doing so hopefully they will continue to move forward with their programs.

Satellos do seen to have a number interesting concepts on the go which could move quickly as well.

I am not planning to bother to vote on this resolution. The result being Management will vote my shares as they see fit.


<< Previous
Bullboard Posts
Next >>